.svg)
About
{Area Name}'s Bio
Howard is an experienced Regenerative Medicine and MedTech executive with proven success in developing and positioning new, technologically advanced products. Howard was previously the CEO of the NuTech companies, where his team built a successful regenerative medicine business focusing on wound care and surgical applications, and Executive Vice President for Organogenesis, Inc., which acquired NuTech in 2017. Howard subsequently led several companies bringing innovative wound care technologies to market. He holds a BSE from Duke University’s School of Engineering and a JD from the Cumberland School of Law.
Articles by {Area Name}
Now is the time to have your voice heard. We are here to help you submit your comments to CMS.
Audits are meant to protect against fraud, but in wound care many providers are now facing aggressive “bad faith” audits driven by financial incentives and bias. This blog explores what’s behind the rise in these audits, their impact on patients and practitioners, and the steps providers can take to prepare, push back, and protect their practices.
After a recent survey we conducted, it is clear most clinicians agreed skin substitutes are highly effective and essential, warning that the proposed rates would reduce patient access, hinder innovation, and threaten the viability of many practices. Read the blog to learn more about our findings.
